All In Biotech

Drug Trial Radar · NCT04169321

Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors

First in Human Safety of [68Ga]-NOTA-hGZP- PET Imaging in Subjects Receiving Checkpoint Inhibitor Immunotherapy

Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

13

Actual

Start

Jun 16, 2020

Primary completion

Mar 30, 2025

Study completion Jun 9, 2025

Sponsor

Lead sponsor
Cytosite Biopharma Inc.Industry
Sponsor type
Industry
Collaborators
Massachusetts General Hospital; University of Alabama at Birmingham; Chang Gung Memorial Hospital
First posted
Nov 19, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

First in Human Safety of \[68Ga\]-NOTA-hGZP PET Imaging in subjects with cancer undergoing treatment with a checkpoint inhibitor either as a monotherapy of in combination I-O therapy

Conditions

  • Solid Tumor, Unspecified, Adult
  • Lymphoma

Interventions

  • Single ArmDrug

    \[68Ga\]-NOTA-hGZP is a PET imaging agent.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with clinically meaningful changes in physical examination findings, vital signs or blood chemistryTime frame: up to 4 to 6 hours post-injection
  2. Number of participants with changes in ECGTime frame: up to 4 to 6 hours post-injection
  3. Number of participants with treatment-related Adverse Events (AEs)Time frame: Between time of injection and 3 days post injection

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Chang-Gung Memorial Hospital

    Taoyuan City, Guishan, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.